miR Scientific to light up need for prostate cancer testing with #CanDoBlue campaign
Six weeks after the launch of miR Scientific’s liquid biopsy prostate cancer test, the medtech company is running a new campaign to literally shine a light on the disease.
miR Scientific launches "Can do Blue" on September 1, 2022, as Prostate Cancer Awareness Month
miR Scientific, LLC announced the launch of national event #CanDoBlue to create awareness of the need for widespread prostate cancer testing during the 2022 Prostate Cancer Awareness Month.
